Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4917 total record number 289 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 298 out of 492
4917 citations found

Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer

Griesmann, H;Drexel, C;Milosevic, N;Sipos, B;Rosendahl, J;Gress, TM;Michl, P;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

Spinal Inhibitory Interneuron Diversity Delineates Variant Motor Microcircuits

Bikoff, JB;Gabitto, MI;Rivard, AF;Drobac, E;Machado, TA;Miri, A;Brenner-Morton, S;Famojure, E;Diaz, C;Alvarez, FJ;Mentis, GZ;Jessell, TM;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

In vivo dynamics of active edema and lethal factors during anthrax

Rougeaux, C;Becher, F;Ezan, E;Tournier, JN;Goossens, PL;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Preventive effect of chrysin on experimental autoimmune uveitis triggered by injection of human IRBP peptide 1-20 in mice

Meng, X;Fang, S;Zhang, Z;Wang, Y;You, C;Zhang, J;Yan, H;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

3H-1,2-dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis

Kuo, PC;Brown, DA;Scofield, BA;Yu, IC;Chang, FL;Wang, PY;Yen, JH;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles

Kessans, SA;Linhart, MD;Meador, LR;Kilbourne, J;Hogue, BG;Fromme, P;Matoba, N;Mor, TS;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Mucosal immunization

    For intranasal (i.n.) administration, immunization cocktails were made by mixing the indicated proteins with PBS. Each dose (20 μl total, 10 μl per nostril) contained either CTB-MPR (35 μg ≡ 12 μg MPER ≡ 2 nmol MPER) with cholera toxin (CT, 1 μg, List Biological Laboratories), VLP preparation (1.1 mg total protein containing 48 μg dgp41 and 48 μg Gag, equivalent to 2 nmol and 1 nmol, respectively) with either CT (1 μg), …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Co-ordinated ocular development from human iPS cells and recovery of corneal function

Hayashi, R;Ishikawa, Y;Sasamoto, Y;Katori, R;Nomura, N;Ichikawa, T;Araki, S;Soma, T;Kawasaki, S;Sekiguchi, K;Quantock, AJ;Tsujikawa, M;Nishida, K;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • EAE induction and LPS instillation:

    Active EAE was induced by immunizing the mice with MOG3555 peptide (100 µg) emulsified in complete Freunds adjuvant (Sigma) containing heat-killed Mycobacterium tuberculosis H37Ra (200 µg per mouse, DIFCO Laboratories) on day 0, and intraperitoneal injection of 200ng pertussis toxin (PTx; List Biological Laboratories) on days 0 and 2. To induce Th17-mediated passive EAE, CD4+ T cells, obtained from 2D2 mice, were polarized with rIL-6 (20ng ml1), rIL-23 (10ng ml1), rTGF- (3ng ml1) and anti-IFN- antibody (4 g ml1) on a plate coated with anti-CD3 and anti-CD28 antibodies for 5 days and adoptively transferred to sublethally irradiated (450 rads) WT and Atg7 CKO mice. PTx (200ng) was intraperitoneally administrated on days 0 and 2. …

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Role of Ventral Subiculum in Context-Induced Relapse to Alcohol Seeking after Punishment-Imposed Abstinence

Marchant, NJ;Campbell, EJ;Whitaker, LR;Harvey, BK;Kaganovsky, K;Adhikary, S;Hope, BT;Heins, RC;Prisinzano, TE;Vardy, E;Bonci, A;Bossert, JM;Shaham, Y;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • CTb into NAc shell:

    We unilaterally injected 40 nl of 1% CTb (List Biological Laboratories) into the NAc shell over 4 min with the needle left in place for an additional 2 min.

    CTb injection site verification:

    Immunohistochemical procedures were based on our previously published work…We selected a 1-in-4 series of sections from the NAc shell of each rat, and immunofluorescence was used to determine CTb injection sites. We repeatedly rinsed free-floating sections in PBS (3 10 min washes) and incubated them for 2 h in PBS containing 0.5% Triton X-100 (PBS-tx) with 10% normal horse serum (NHS). We then incubated all sections for at least 48 h at 4°C in goat anti-CTb primary antibody (1:5000, List Biological Laboratories, 703),

    Fos protein and CTb double labeling:

    We processed a 1-in-4 series of vmPFC, PVT, BLA, and vSub for immunohistochemical detection of Fos protein and CTb…We then incubated sections for at least 48 h at 4°C in PBS-tx with 2% NHS, rabbit anti-c-Fos primary antibody (1:8000, Cell Signaling Technology, Phospho-c-Fos, 5348S) and goat anti-CTb primary antibody (1:5000, List Biological Laboratories, 703).

    Product #104 – Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt
    Product #703 – Anti-Cholera Toxin B Subunit (Goat)

Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System

Hasarmeh, M;Itzik, A;Weidenfeld, J;Ovadia, H;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer